STAAR Surgical Company (STAA) DCF Valuation

STAAR Surgical Company (STAA) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

STAAR Surgical Company (STAA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our (STAA) DCF Calculator enables you to evaluate STAAR Surgical Company's valuation using real-world financial data, offering complete flexibility to modify all key parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 150.2 163.5 230.5 284.4 322.4 392.2 477.1 580.4 706.1 859.0
Revenue Growth, % 0 8.84 41 23.4 13.37 21.65 21.65 21.65 21.65 21.65
EBITDA 15.6 9.9 37.0 48.3 34.8 47.2 57.5 69.9 85.1 103.5
EBITDA, % 10.35 6.03 16.05 16.99 10.8 12.05 12.05 12.05 12.05 12.05
Depreciation 3.7 3.1 3.6 4.5 5.1 7.1 8.7 10.6 12.9 15.7
Depreciation, % 2.46 1.89 1.58 1.59 1.59 1.82 1.82 1.82 1.82 1.82
EBIT 11.9 6.8 33.3 43.8 29.7 40.1 48.8 59.3 72.2 87.8
EBIT, % 7.89 4.14 14.47 15.4 9.21 10.22 10.22 10.22 10.22 10.22
Total Cash 120.0 152.5 199.7 211.6 220.7 315.9 384.3 467.5 568.7 691.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 31.0 35.2 43.5 62.4 98.0
Account Receivables, % 20.64 21.55 18.89 21.96 30.39
Inventories 17.1 18.1 17.3 24.2 35.1 38.7 47.1 57.3 69.7 84.8
Inventories, % 11.41 11.08 7.5 8.5 10.9 9.88 9.88 9.88 9.88 9.88
Accounts Payable 8.1 2.8 8.7 11.6 13.6 15.0 18.3 22.2 27.0 32.9
Accounts Payable, % 5.36 1.72 3.77 4.07 4.2 3.83 3.83 3.83 3.83 3.83
Capital Expenditure -10.2 -8.4 -13.6 -18.1 -18.2 -23.4 -28.5 -34.6 -42.2 -51.3
Capital Expenditure, % -6.78 -5.14 -5.92 -6.37 -5.64 -5.97 -5.97 -5.97 -5.97 -5.97
Tax Rate, % 36.65 36.65 36.65 36.65 36.65 36.65 36.65 36.65 36.65 36.65
EBITAT 12.8 4.8 29.3 37.9 18.8 32.8 39.9 48.6 59.1 71.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -33.8 -10.9 17.7 1.4 -38.8 23.4 -4.3 -5.2 -6.3 -7.7
WACC, % 7.27 7.23 7.25 7.25 7.22 7.24 7.24 7.24 7.24 7.24
PV UFCF
SUM PV UFCF 3.8
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) -8
Terminal Value -245
Present Terminal Value -173
Enterprise Value -169
Net Debt -147
Equity Value -22
Diluted Shares Outstanding, MM 49
Equity Value Per Share -0.45

What You Will Receive

  • Comprehensive Financial Model: STAAR Surgical Company’s actual performance data facilitates accurate DCF valuation.
  • Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates provide immediate insights as you adjust parameters.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Flexible and Reusable: Designed for adaptability, enabling frequent use for in-depth forecasts.

Key Features

  • Comprehensive Data: STAAR Surgical Company’s historical financial statements and pre-filled projections.
  • Customizable Variables: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: Observe STAAR Surgical’s intrinsic value recalculating instantly.
  • Visual Representation: Dashboard graphs illustrate valuation outcomes and essential metrics.
  • Precision Focused: A reliable tool designed for analysts, investors, and finance professionals.

How It Works

  • 1. Download the Template: Obtain and open the Excel file containing STAAR Surgical Company's (STAA) preloaded data.
  • 2. Adjust Key Inputs: Modify essential parameters such as growth rates, WACC, and capital expenditures.
  • 3. Analyze Results in Real-Time: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Different Scenarios: Evaluate various forecasts to understand diverse valuation results.
  • 5. Make Informed Decisions: Present expert valuation analyses to back your strategic choices.

Why Choose This Calculator for STAAR Surgical Company (STAA)?

  • User-Friendly Interface: Tailored for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters easily to suit your financial analysis.
  • Real-Time Feedback: Observe immediate updates to STAAR Surgical's valuation as you tweak inputs.
  • Pre-Loaded Data: Comes with STAAR Surgical’s latest financial information for swift assessments.
  • Preferred by Experts: Utilized by investors and analysts for making well-informed choices.

Who Should Use STAAR Surgical Company (STAA)?

  • Healthcare Investors: Make informed investment choices with advanced insights into ophthalmic technologies.
  • Market Analysts: Streamline your analysis process with comprehensive data on eye care innovations.
  • Medical Consultants: Efficiently tailor presentations and reports for clients in the healthcare sector.
  • Ophthalmology Enthusiasts: Enhance your knowledge of vision correction solutions through real-world applications.
  • Educators and Students: Utilize it as a hands-on resource in medical and business education programs.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for STAAR Surgical Company (STAA).
  • Real-World Data: STAAR Surgical’s historical and projected financials preloaded for in-depth analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into the company's performance.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics specific to STAAR Surgical Company (STAA).
  • Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for informed decision-making.

No products were found matching.